Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The purpose of this study is to determine if gastric/esophageal, lung, pancreatic, bladder and sarcoma patients show benefit from brivanib treatment. Patients who clearly do, stay on treatment. Those in which it is unclear will be randomized to continue or withdraw treatment to determine whether that benefit is related to brivanib
Epistemonikos ID: 01d6c34a0e1da29b7f6ca44ca073721a3365281a
First added on: May 04, 2024